— Early sign of Alzheimer's reversed in lab — One of the earliest known impairments caused by Alzheimer's disease - loss of sense of smell - can be restored by removing a plaque-forming protein in a mouse model of the disease,…
— Parental controls on embryonic development? — When a sperm fertilises an egg, each contributes a set of chromosomes to the resulting embryo, which at these very early stages is called a zygote. Early on, zygotic genes are inert,…
— Newly discovered heart stem cells make muscle and bone — Researchers have identified a new and relatively abundant pool of stem cells in the heart. The findings in the December issue of Cell Stem Cell, a Cell Press publication, show that…
— BUSM researchers develop blood test to detect membranous nephropathy — Research conducted by a pair of physicians at Boston University School of Medicine (BUSM) and Boston Medical Centre (BMC) has led to the development of a test that can help diagnose…
— New hip implants no better than traditional implants — New hip implants appear to have no advantage over traditional implants, suggests a review of the evidence published on bmj.com today…
— Action needed to improve men's health in Europe — Policies aimed specifically at men are urgently needed to improve the health of Europe's men, say experts on bmj.com today…
— Probiotics reduce infections for patients in intensive care — Traumatic brain injury is associated with a profound suppression of the patient's ability to fight infection. At the same time the patient also often suffers hyper-inflammation, due…
— High blood sugar levels in older women linked to colorectal cancer — Elevated blood sugar levels are associated with an increased risk of colorectal cancer, according to a study led by researchers at Albert Einstein College of Medicine of Yeshiva University.…
— Engineered botulism toxins could have broader role in medicine — The most poisonous substance on Earth - already used medically in small doses to treat certain nerve disorders and facial wrinkles - could be re-engineered for an expanded role in helping…
Cardiovascular disease can be detected earlier during sleep
A specially customised pulse oximeter attached to the finger can be used to detect changes in heart and vessel function while you sleep, and this simple technique can even identify patients at increased risk of cardiovascular disease, reveals research from the University of Gothenburg, Sweden.
A pilot study of 148 people showed that more than 80% of high-risk patients were picked up by this simple and risk-free measurement technique. The results were published recently in the journal Chest.
In the study, researchers used a modified version of the pulse oximeter currently used to detect various sleep disorders during the night, such as apnoea. The method is based on the measurement of five components of the signal from the finger: pulse wave attenuation, pulse rate acceleration, pulse propagation time, respiration-related pulse oscillation and oxygen desaturation.
'We then weigh up these components in a model to assess how great a risk the patient runs of cardiovascular disease,' says Ludger Grote, associate professor at the Centre for Sleep and Vigilance Disorders at the Sahlgrenska Academy and senior consultant at Sahlgrenska University Hospital. 'We believe that the patient's values reflect the risk at least as well as the individual's risk factors 'on paper.''
The method may result in quicker and easier identification of patients at high risk of cardiovascular disease. It is hoped that it can also be used to assess the effects of treatment for cardiovascular disease, such as how weight loss and exercise can help prevent problems.
The research results are the result of teamwork between docent Ludger Grote, professor Jan Hedner, researcher Zou Ding and researcher Derek Eder from the Sahlgrenska Academy and computer engineer Dirk Sommermeyer from Karlsruhe Institute of Technology in Germany, a visiting researcher at the Sahlgrenska Academy.
The team is now developing prototypes for a future portable device that can be used clinically. Before it can be taken into use, larger research studies are needed to confirm the results. Grote says that the team has already begun this process.
Or subscribe for our Newsletter, a free e-mail publication. It is published practically every day.
Timing is everything when it comes to childhood asthma
Researchers at IRB Barcelona produce more data on key genes in diabetes
Alzheimer's disease breakthrough
Alzheimer's gene slows export of toxic amyloid-beta protein